Skip to main content
Erschienen in: Annals of Surgical Oncology 10/2020

03.04.2020 | Endocrine Tumors

Utility of a Second 99mTc-MIBI Scintigraphy Before Reoperation for Patients With Persistent Sporadic Primary Hyperparathyroidism: Results of a Retrospective Multicenter Study

verfasst von: Samuel Frey, MD, Clément Couëtte, MD, Christophe Trésallet, MD, PhD, Antoine Hamy, MD, Cécile Caillard, MD, Claire Blanchard, MD, PhD, Fabrice Menegaux, MD, PhD, Nathalie Chereau, MD, Matthieu Wargny, MD, Charlotte Lussey-Lepoutre, MD, PhD, Delphine Drui, MD, Catherine Ansquer, MD, Eric Mirallié, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Persistent primary hyperparathyroidism (PHPT) occurs in 2.5% to 15% of cases after parathyroidectomy. Few studies have evaluated the best pre-reoperative imaging approaches for persistent sporadic PHPT. This retrospective multicenter study aimed to evaluate the benefit of a second pre-reoperative 99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy for patients with persistent PHPT who had a 99mTc-MIBI before their initial surgery.

Methods

The study enrolled 50 patients with persistent sporadic PHPT who had reoperation between 2006 and 2016 in three French University Hospitals (Angers, Nantes, and La Pitié Salpêtrière-Paris). Preoperative 99mTc-MIBI scan was performed before each operation.

Results

After the reoperation, 42 patients (84%) were cured. By the second 99mTc-MIBI, 31 patients (62%) had a removed gland identified. A new pathologic gland was identified by a second 99mTc-MIBI in 25 patients (50%), and this imaging permitted correction of an initial surgical error in six patients (12%). A second 99mTc-MIBI showed a sensitivity of 63%, a specificity of 89%, a positive predictive value (PPV) of 78%, and a negative predictive value (NPV) of 80%. A concordant second 99mTc-MIBI and ultrasonography (17 patients) showed a sensitivity of 70%, a specificity of 81%, a PPV of 70%, and an NPV of 81%.

Conclusions

Performing a second 99mTc-MIBI scan permitted 62% of the persistent PHPT patients to be cured, allowing identification of new pathologic glands in 50% of the cases and correction of an initial surgical error in 12% of the cases, with high specificity and PPV. These results reinforce the fact that a second 99mTc-MIBI scan should be performed at first intention before reoperation of patients with persistent PHPT, regardless of the result from the initial 99mTc-MIBI scan.
Literatur
1.
Zurück zum Zitat Zahrani A, Levine M. Primary hyperparathyroidism. Lancet. 1997;349:1233–8.CrossRef Zahrani A, Levine M. Primary hyperparathyroidism. Lancet. 1997;349:1233–8.CrossRef
2.
Zurück zum Zitat Edafe O, Collins E, Ubhi C, Balasubramanian S. Current predictive models do not accurately differentiate between single and multi-gland disease in primary hyperparathyroidism: a retrospective cohort study of two endocrine surgery units. Ann R Coll Surg Engl. 2018;100:140–5.CrossRef Edafe O, Collins E, Ubhi C, Balasubramanian S. Current predictive models do not accurately differentiate between single and multi-gland disease in primary hyperparathyroidism: a retrospective cohort study of two endocrine surgery units. Ann R Coll Surg Engl. 2018;100:140–5.CrossRef
4.
Zurück zum Zitat Karakas E, Schneider R, Rothmund M, Bartsch DK, Schlosser K. Initial surgery for benign primary hyperparathyroidism: an analysis of 1300 patients in a teaching hospital. World J Surg. 2014;38:2011–8.CrossRef Karakas E, Schneider R, Rothmund M, Bartsch DK, Schlosser K. Initial surgery for benign primary hyperparathyroidism: an analysis of 1300 patients in a teaching hospital. World J Surg. 2014;38:2011–8.CrossRef
5.
Zurück zum Zitat Suliburk J, Sywak M, Sidhu S, Delbridge L. 1000 minimally invasive parathyroidectomies without intraoperative parathyroid hormone measurement: lessons learned: 1000 MIPs: lessons learned. ANZ J Surg. 2011;81:362–5.CrossRef Suliburk J, Sywak M, Sidhu S, Delbridge L. 1000 minimally invasive parathyroidectomies without intraoperative parathyroid hormone measurement: lessons learned: 1000 MIPs: lessons learned. ANZ J Surg. 2011;81:362–5.CrossRef
6.
Zurück zum Zitat Egan R, Scott-Coombes D. The surgical management of sporadic primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32:847–59.CrossRef Egan R, Scott-Coombes D. The surgical management of sporadic primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32:847–59.CrossRef
7.
Zurück zum Zitat Yeh M, Wiseman J, Chu S, et al. Population-level predictors of persistent hyperparathyroidism. Surgery. 2011;150:1113–9.CrossRef Yeh M, Wiseman J, Chu S, et al. Population-level predictors of persistent hyperparathyroidism. Surgery. 2011;150:1113–9.CrossRef
8.
Zurück zum Zitat Guerin C, Paladino NC, Lowery A, Castinetti F, Taieb D, Sebag F. Persistent and recurrent hyperparathyroidism. Updates Surg. 2017;69:161–9.CrossRef Guerin C, Paladino NC, Lowery A, Castinetti F, Taieb D, Sebag F. Persistent and recurrent hyperparathyroidism. Updates Surg. 2017;69:161–9.CrossRef
9.
Zurück zum Zitat Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151:959.CrossRef Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151:959.CrossRef
10.
Zurück zum Zitat Hessman O, Stålberg P, Sundin A, et al. High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg. 2008;32:774–81.CrossRef Hessman O, Stålberg P, Sundin A, et al. High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg. 2008;32:774–81.CrossRef
11.
Zurück zum Zitat Bergenfelz AOJ, Hellman P, Harrison B, Sitges-Serra A, Dralle H. Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg. 2009;394:761–4.CrossRef Bergenfelz AOJ, Hellman P, Harrison B, Sitges-Serra A, Dralle H. Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg. 2009;394:761–4.CrossRef
12.
Zurück zum Zitat Lubitz CC, Hunter GJ, Hamberg LM, et al. Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism. Surgery. 2010;148:1129–38.CrossRef Lubitz CC, Hunter GJ, Hamberg LM, et al. Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism. Surgery. 2010;148:1129–38.CrossRef
13.
Zurück zum Zitat Amadou C, Bera G, Ezziane M, et al. 18F-Fluorocholine PET/CT and parathyroid 4D computed tomography for primary hyperparathyroidism: the challenge of reoperative patients. World J Surg. 2019;43:1232–42.CrossRef Amadou C, Bera G, Ezziane M, et al. 18F-Fluorocholine PET/CT and parathyroid 4D computed tomography for primary hyperparathyroidism: the challenge of reoperative patients. World J Surg. 2019;43:1232–42.CrossRef
14.
Zurück zum Zitat Mariette C, Pellissier L, Combemale F, Quievreux JL, Carnaille B, Proye C. Reoperation for persistent or recurrent primary hyperparathyroidism. Langenbecks Arch Surg. 1998;383:174–9.CrossRef Mariette C, Pellissier L, Combemale F, Quievreux JL, Carnaille B, Proye C. Reoperation for persistent or recurrent primary hyperparathyroidism. Langenbecks Arch Surg. 1998;383:174–9.CrossRef
15.
Zurück zum Zitat Szmidt J. Reoperations for persistent or recurrent primary hyperparathyroidism: results of a retrospective cohort study at a tertiary referral center. Med Sci Monit. 2014;20:1604–12.CrossRef Szmidt J. Reoperations for persistent or recurrent primary hyperparathyroidism: results of a retrospective cohort study at a tertiary referral center. Med Sci Monit. 2014;20:1604–12.CrossRef
16.
Zurück zum Zitat Blanchard C, Mathonnet M, Sebag F, et al. Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study. Ann Surg Oncol. 2014;21:3534–40.CrossRef Blanchard C, Mathonnet M, Sebag F, et al. Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study. Ann Surg Oncol. 2014;21:3534–40.CrossRef
17.
Zurück zum Zitat Bannani S, Christou N, Guérin C, et al. Effect of parathyroidectomy on quality of life and nonspecific symptoms in normocalcaemic primary hyperparathyroidism. Br J Surg. 2018;105:223–9.CrossRef Bannani S, Christou N, Guérin C, et al. Effect of parathyroidectomy on quality of life and nonspecific symptoms in normocalcaemic primary hyperparathyroidism. Br J Surg. 2018;105:223–9.CrossRef
18.
Zurück zum Zitat Richards ML. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg. 2011;146:280.CrossRef Richards ML. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg. 2011;146:280.CrossRef
19.
Zurück zum Zitat Sebag F, Shen W, Brunaud L, Kebebew E, Duh QY, Clark OH. Intraoperative parathyroid hormone assay and parathyroid reoperations. Surgery. 2003;134:1049–55.CrossRef Sebag F, Shen W, Brunaud L, Kebebew E, Duh QY, Clark OH. Intraoperative parathyroid hormone assay and parathyroid reoperations. Surgery. 2003;134:1049–55.CrossRef
20.
Zurück zum Zitat Wells S, Debendetti M, Doherty G. Recurrent or persistent hyperparathyroidism. J Bone Miner Res. 2002;2:158–62. Wells S, Debendetti M, Doherty G. Recurrent or persistent hyperparathyroidism. J Bone Miner Res. 2002;2:158–62.
21.
Zurück zum Zitat Chen H, Wang T, Yen T, et al. Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume. Trans Meet Am Surg Assoc. 2010;128:308–13. Chen H, Wang T, Yen T, et al. Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume. Trans Meet Am Surg Assoc. 2010;128:308–13.
22.
Zurück zum Zitat Karakas E, Müller H-H, Schlosshauer T, Rothmund M, Bartsch D. Reoperations for primary hyperparathyroidism: improvement of outcome over two decades. Langenbecks Arch Surg. 2013;398:99–106.CrossRef Karakas E, Müller H-H, Schlosshauer T, Rothmund M, Bartsch D. Reoperations for primary hyperparathyroidism: improvement of outcome over two decades. Langenbecks Arch Surg. 2013;398:99–106.CrossRef
23.
Zurück zum Zitat Feingold D, Alexander H, Chen C, et al. Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas. Surgery. 2000;128:1103–10.CrossRef Feingold D, Alexander H, Chen C, et al. Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas. Surgery. 2000;128:1103–10.CrossRef
24.
Zurück zum Zitat Henry J-F. Reoperation for primary hyperparathyroidism: tips and tricks. Langenbecks Arch Surg. 2010;395:103–9.CrossRef Henry J-F. Reoperation for primary hyperparathyroidism: tips and tricks. Langenbecks Arch Surg. 2010;395:103–9.CrossRef
25.
Zurück zum Zitat Udelsman R. Approach to the patient with persistent or recurrent primary hyperparathyroidism. J Clin Endocrinol Metab. 2011;96:2950–8.CrossRef Udelsman R. Approach to the patient with persistent or recurrent primary hyperparathyroidism. J Clin Endocrinol Metab. 2011;96:2950–8.CrossRef
26.
Zurück zum Zitat Witteveen J, Kievit J, Stokkel M, Morreau H, Romijn J, Hamdy N. Limitations of Tc99m-MIBI-SPECT imaging scans in persistent primary hyperparathyroidism. World J Surg. 2011;35:128–39.CrossRef Witteveen J, Kievit J, Stokkel M, Morreau H, Romijn J, Hamdy N. Limitations of Tc99m-MIBI-SPECT imaging scans in persistent primary hyperparathyroidism. World J Surg. 2011;35:128–39.CrossRef
27.
Zurück zum Zitat Piciucchi S, Barone D, Dubini A, Gavelli G, Oboldi D. Primary hyperparathyroidism: imaging to pathology. J Clin Imaging Sci. 2012;2:59.CrossRef Piciucchi S, Barone D, Dubini A, Gavelli G, Oboldi D. Primary hyperparathyroidism: imaging to pathology. J Clin Imaging Sci. 2012;2:59.CrossRef
28.
Zurück zum Zitat Brown S, Lee J, Christie J, et al. Four-dimensional computed tomography for parathyroid localization: a new imaging modality. ANZ J Surg. 2015;85:483–7.CrossRef Brown S, Lee J, Christie J, et al. Four-dimensional computed tomography for parathyroid localization: a new imaging modality. ANZ J Surg. 2015;85:483–7.CrossRef
29.
Zurück zum Zitat Schalin-Jantti C, Ryhanen E, Heiskanen I, et al. Planar scintigraphy with 123I/99mTc-Sestamibi, 99mTc-Sestamibi SPECT/CT, 11C-Methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism? J Nucl Med. 2013;54:739–47.CrossRef Schalin-Jantti C, Ryhanen E, Heiskanen I, et al. Planar scintigraphy with 123I/99mTc-Sestamibi, 99mTc-Sestamibi SPECT/CT, 11C-Methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism? J Nucl Med. 2013;54:739–47.CrossRef
30.
Zurück zum Zitat Kelly H, Hamberg L, Hunter G. 4D-CT for preoperative localization of abnormal parathyroid glands in patients with hyperparathyroidism: accuracy and ability to stratify patients by unilateral versus bilateral disease in surgery-naïve and re-exploration patients. Am J Neuroradiol. 2014;35:176–81.CrossRef Kelly H, Hamberg L, Hunter G. 4D-CT for preoperative localization of abnormal parathyroid glands in patients with hyperparathyroidism: accuracy and ability to stratify patients by unilateral versus bilateral disease in surgery-naïve and re-exploration patients. Am J Neuroradiol. 2014;35:176–81.CrossRef
31.
Zurück zum Zitat Hamidi M, Sullivan M, Hunter G, et al. 4D-CT is superior to ultrasound and sestamibi for localizing recurrent parathyroid disease. Ann Surg Oncol. 2018;25:1403–9.CrossRef Hamidi M, Sullivan M, Hunter G, et al. 4D-CT is superior to ultrasound and sestamibi for localizing recurrent parathyroid disease. Ann Surg Oncol. 2018;25:1403–9.CrossRef
32.
Zurück zum Zitat Hindie E, Zanotti-Fregonara P, Tabarin A, et al. The role of radionuclide imaging in the surgical management of primary hyperparathyroidism. J Nucl Med. 2015;56:737–44.CrossRef Hindie E, Zanotti-Fregonara P, Tabarin A, et al. The role of radionuclide imaging in the surgical management of primary hyperparathyroidism. J Nucl Med. 2015;56:737–44.CrossRef
33.
Zurück zum Zitat Weber T, Gottstein M, Schwenzer S, Beer A, Luster M. Is C-11 methionine PET/CT able to localise sestamibi-negative parathyroid adenomas? World J Surg. 2017;41:980–5.CrossRef Weber T, Gottstein M, Schwenzer S, Beer A, Luster M. Is C-11 methionine PET/CT able to localise sestamibi-negative parathyroid adenomas? World J Surg. 2017;41:980–5.CrossRef
34.
Zurück zum Zitat Sun P, Thompson S, Andrews J, et al. Selective parathyroid hormone venous sampling in patients with persistent or recurrent primary hyperparathyroidism and negative, equivocal or discordant noninvasive imaging. World J Surg. 2016;40:2956–63.CrossRef Sun P, Thompson S, Andrews J, et al. Selective parathyroid hormone venous sampling in patients with persistent or recurrent primary hyperparathyroidism and negative, equivocal or discordant noninvasive imaging. World J Surg. 2016;40:2956–63.CrossRef
35.
Zurück zum Zitat Michaud L, Burgess A, Huchet V, et al. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab. 2014;99:4531–6.CrossRef Michaud L, Burgess A, Huchet V, et al. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab. 2014;99:4531–6.CrossRef
Metadaten
Titel
Utility of a Second 99mTc-MIBI Scintigraphy Before Reoperation for Patients With Persistent Sporadic Primary Hyperparathyroidism: Results of a Retrospective Multicenter Study
verfasst von
Samuel Frey, MD
Clément Couëtte, MD
Christophe Trésallet, MD, PhD
Antoine Hamy, MD
Cécile Caillard, MD
Claire Blanchard, MD, PhD
Fabrice Menegaux, MD, PhD
Nathalie Chereau, MD
Matthieu Wargny, MD
Charlotte Lussey-Lepoutre, MD, PhD
Delphine Drui, MD
Catherine Ansquer, MD
Eric Mirallié, MD
Publikationsdatum
03.04.2020
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 10/2020
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08428-3

Weitere Artikel der Ausgabe 10/2020

Annals of Surgical Oncology 10/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.